According to AstraZeneca's latest financial reports and stock price the company's current Operating Margin is 5.63%. At the end of 2022 the company had an Operating Margin of 5.64%.
Year | Operating Margin | Change |
---|---|---|
2022 | 5.64% | -896.22% |
2021 | -0.71% | -104.81% |
2020 | 14.71% | 131.75% |
2019 | 6.35% | -29.64% |
2018 | 9.02% | -8.99% |
2017 | 9.91% | -35.8% |
2016 | 15.44% | 24.32% |
2015 | 12.42% | 160.13% |
2014 | 4.77% | -62.42% |
2013 | 12.71% | -53.95% |
2012 | 27.59% | -25.06% |
2011 | 36.82% | 11.58% |
2010 | 32.99% | 0.15% |
2009 | 32.94% | 19.92% |
2008 | 27.47% | 1.72% |
2007 | 27.01% | -16.3% |
2006 | 32.27% | 15.92% |
2005 | 27.84% | 23.13% |
2004 | 22.61% | 1.41% |
2003 | 22.29% | -1.48% |
2002 | 22.63% | -8.55% |
2001 | 24.74% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 22.88% | 306.39% | ๐บ๐ธ USA |
Novartis NVS | 17.27% | 206.75% | ๐จ๐ญ Switzerland |
Pfizer PFE | 34.61% | 514.74% | ๐บ๐ธ USA |
Abbott Laboratories ABT | 15.60% | 177.09% | ๐บ๐ธ USA |
Eli Lilly LLY | 24.66% | 338.01% | ๐บ๐ธ USA |
Sanofi SNY | 18.21% | 223.45% | ๐ซ๐ท France |
Biogen BIIB | 31.30% | 455.95% | ๐บ๐ธ USA |
Merck MRK | 27.73% | 392.54% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 19.24% | 241.74% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | 22.54% | 300.36% | ๐ฌ๐ง UK |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.